Tevogen Bio Holdings, Inc. logo

Tevogen Bio Holdings, Inc. (TVGN) Q4 2024 Annual Earnings

TVGN·Reported April 2, 2025

Diluted EPS came in at $-2.60, missed the $-0.03 consensus by $2.56.

Diluted EPS
$-2.60missed by $2.56
Consensus: $-0.03
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q4 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Tevogen Bio Holdings, Inc.'s Q4 2024 earnings report.

Tevogen Bio Holdings, Inc. (TVGN) reported Q4 2024 earnings on April 2, 2025.

Tevogen Bio Holdings, Inc. reported diluted EPS of $-2.60 for Q4 2024.

EPS missed the consensus estimate of $-0.03 by $2.56.

You can read the 10-K periodic report (0001641172-25-002426) directly on SEC EDGAR. The filing index links above go to sec.gov.